Search Results - "Melegaro, A"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales by Melegaro, A., Edmunds, W.J.

    Published in Vaccine (22-10-2004)
    “…: To establish whether universal vaccination of infants with the pneumococcal conjugate vaccine is likely to be cost-effective from the perspective of the…”
    Get full text
    Journal Article
  2. 2

    The containment of potential outbreaks triggered by imported Chikungunya cases in Italy: a cost utility epidemiological assessment of vector control measures by Trentini, F., Poletti, P., Baldacchino, F., Drago, A., Montarsi, F., Capelli, G., Rizzoli, A., Rosà, R., Rizzo, C., Merler, S., Melegaro, A.

    Published in Scientific reports (13-06-2018)
    “…The arrival of infected travelers from endemic regions can trigger sustained autochthonous transmission of mosquito-borne pathogens in Europe. In 2007 a…”
    Get full text
    Journal Article
  3. 3

    Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales by van Hoek, A.J, Gay, N, Melegaro, A, Opstelten, W, Edmunds, W.J

    Published in Vaccine (25-02-2009)
    “…Abstract A live-attenuated vaccine against herpes zoster (HZ) has been approved for use, on the basis of a large-scale clinical trial that suggests that the…”
    Get full text
    Journal Article
  4. 4

    Assessing the burden of influenza and other respiratory infections in England and Wales by Pitman, R.J, Melegaro, A, Gelb, D, Siddiqui, M.R, Gay, N.J, Edmunds, W.J

    Published in The Journal of infection (01-06-2007)
    “…Summary Objectives To estimate the burden of influenza in England and Wales, in terms of general practice consultations, hospital admissions and deaths…”
    Get full text
    Journal Article
  5. 5

    A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting by HUSSAIN, M., MELEGARO, A., PEBODY, R. G., GEORGE, R., EDMUNDS, W. J., TALUKDAR, R., MARTIN, S. A., EFSTRATIOU, A., MILLER, E.

    Published in Epidemiology and infection (01-10-2005)
    “…A 10-month longitudinal household study of pre-school children and their families was undertaken with monthly visits collecting epidemiological data and…”
    Get full text
    Journal Article
  6. 6

    Estimating the transmission parameters of pneumococcal carriage in households by MELEGARO, A., GAY, N. J., MEDLEY, G. F.

    Published in Epidemiology and infection (01-06-2004)
    “…This paper analyses Streptococcus pneumoniae transmission dynamics in households using longitudinal data on pneumococcal (Pnc) carriage in the United Kingdom…”
    Get full text
    Journal Article
  7. 7

    The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe by Santermans, E, Goeyvaerts, N, Melegaro, A, Edmunds, W.J, Faes, C, Aerts, M, Beutels, P, Hens, N

    Published in Epidemics (01-06-2015)
    “…Highlights • We investigate the transmissibility of VZV in 12 European countries. • We introduce the effective reproduction number as model eligibility…”
    Get full text
    Journal Article
  8. 8

    The current burden of pneumococcal disease in England and Wales by Melegaro, A., Edmunds, W.J., Pebody, R., Miller, E., George, R.

    Published in The Journal of infection (2006)
    “…To evaluate the potential impact of various pneumococcal conjugate vaccination strategies, it is critical to ascertain the pre-vaccination epidemiology and to…”
    Get full text
    Journal Article
  9. 9

    Measurement and interpretation of pneumococcal IgG levels for clinical management by BALMER, P., NORTH, J., BAXTER, D., STANFORD, E., MELEGARO, A., KACZMARSKI, E. B., MILLER, E., BORROW, R.

    Published in Clinical and experimental immunology (01-09-2003)
    “…SUMMARY The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination. Results…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    The relative importance of frequency of contacts and duration of exposure for the spread of directly transmitted infections by De Cao, Elisabetta, Zagheni, Emilio, Manfredi, Piero, Melegaro, Alessia

    Published in Biostatistics (Oxford, England) (01-07-2014)
    “…The recent availability of survey data on social contact patterns has made possible important advances in the understanding of the social determinants of the…”
    Get full text
    Journal Article
  13. 13

    Antibody Responses to Nasopharyngeal Carriage of Streptococcus pneumoniae in Adults: A Longitudinal Household Study by Goldblatt, David, Hussain, Mahein, Andrews, Nick, Ashton, Lindsey, Virta, Camilla, Melegaro, Alessia, Pebody, Richard, George, Robert, Soininen, Anu, Edmunds, John, Gay, Nigel, Kayhty, Helena, Miller, Elizabeth

    Published in The Journal of infectious diseases (01-08-2005)
    “…BackgroundNatural immunity to Streptococcus pneumoniae is thought to be induced by exposure to S. pneumoniae or cross-reactive antigens. No longitudinal…”
    Get full text
    Journal Article
  14. 14

    The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses by Melegaro, Alessia, Edmunds, W. John

    Published in European journal of epidemiology (01-04-2004)
    “…A 23-valent polysaccharide pneumococcal vaccine (PPV) has been available in the UK for more than 20 years and is currently recommended for use in high-risk…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales by Melegaro, Alessia, Edmunds, W. John

    Published in European journal of epidemiology (01-04-2004)
    “…The 23-valent pneumococcal polysaccharide vaccine (PPV) has been available for a number of years and is recommended for high-risk categories. Relatively…”
    Get full text
    Journal Article
  17. 17

    The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales by Edmunds, W.John, Brisson, Marc, Melegaro, Alessia, Gay, Nigel J.

    Published in Vaccine (31-01-2002)
    “…A cost-effectiveness analysis of the introduction of acellular pertussis booster doses at either 4 or 15 years of age was performed. A transmission dynamic…”
    Get full text
    Journal Article
  18. 18

    The early phase of the COVID-19 outbreak in Lombardy, Italy by Cereda, D, Tirani, M, Rovida, F, Demicheli, V, Ajelli, M, Poletti, P, Trentini, F, Guzzetta, G, Marziano, V, Barone, A, Magoni, M, Deandrea, S, Diurno, G, Lombardo, M, Faccini, M, Pan, A, Bruno, R, Pariani, E, Grasselli, G, Piatti, A, Gramegna, M, Baldanti, F, Melegaro, A, Merler, S

    Published 20-03-2020
    “…In the night of February 20, 2020, the first case of novel coronavirus disease (COVID-19) was confirmed in the Lombardy Region, Italy. In the week that…”
    Get full text
    Journal Article